BioStem Technologies to begin trading on Nasdaq Capital Market Aug. 7 under BSEM ticker
BSEM•Nasdaq Capital Market listing to begin Aug. 7
BioStem Technologies will move its common stock listing to the Nasdaq Capital Market from the OTC market.
Trading on Nasdaq is set to start Aug. 7, 2026 under ticker BSEM.
Nasdaq completed its review of the listing application, clearing the company to begin trading on the exchange.
The ticker will remain unchanged; no shareholder action is required.
